Sylvamo (SLVM) Q3 2026 Earnings Call Transcript

Sylvamo (SLVM) reported Q3 2026 net sales of $645 million, adjusted EBITDA of $128 million, and adjusted earnings of $1.33 per share. The company agreed to divest European operations, retaining a 20% interest, and plans capacity expansions in the U.S. Management highlighted price increases and operational improvements but noted ongoing cost pressures. The board did not renew the shareholder rights plan. (350 characters)

Original reporting
Published Nov 6, 2026, 7:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 7:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sylvamo (SLVM) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SLVMBullishMed
01

Why it matters

The Q3 results highlight operational improvements and strategic refocusing, which may influence investor sentiment.

02

Market read

First report of Sylvamo's Q3 earnings provides fresh data for traders evaluating paper sector exposure.

03

What to watch

Rising input and transportation costs may erode margin gains despite price increases.

Relevance 7/10Novelty 7/10Timing: today

Background

Sylvamo is a specialty paper producer focusing on uncoated freesheet products.

Company-level read

Ticker impact

$SLVMBullishHigh confidence
Context

Q3 2026 earnings call disclosed net sales of $645M, adjusted EBITDA of $128M and a $0.45 dividend, all new information.

Expected impact

likely modest upside as market prices in stronger margins and dividend payout

Evidence & confidence

Higher margins, dividend initiation and strategic divestiture signal improved cash flow and focus on core markets.

Market effects

Paper industry may see renewed focus on North American demand as Sylvamo exits Europe.

North American paper market could benefit from increased capacity and reduced import reliance.

Limited to specialty paper segment; broader market impact minimal.

Counterpoint

Divestiture could signal underlying weakness in European operations, risking future earnings.

Key entities

  • John Van Sims

    Chief Executive Officer of Sylvamo.

  • Donald Paul Devlin

    Chief Financial Officer of Sylvamo.

Related articles

$SLVMMedAI 8/10

Sylvamo Q3 Earnings Call Highlights

Sylvamo (SLVM) reported Q3 adjusted EBITDA improved by $25M due to price increases, with flat volume. Input costs rose by $6M, but the company expects to mitigate further increases. Projects at Eastover and Sumter mills are on track, with expected capacity expansions. The company declined to update free cash flow targets post-Europe transaction but reaffirmed capital allocation priorities, including dividends and share repurchases.

$SLVMMed

Sylvamo Corp (SLVM) (Q3 2026) Earnings Call Highlights: Adjusted EBITDA Nearly Doubles

Sylvamo Corp (SLVM) reported Q3 2026 adjusted EBITDA of $128M, nearly doubling from Q2. CEO John Sims and CFO John Devlin discussed 2027 outlook, noting uncertainties but expecting $25M of non-repeat items. They also addressed the Europe deal, Sumter sheeter expansion, and cost mitigation strategies. The company's shareholder rights plan will expire on Nov 9, 2026. North America shipments are expected to be flat in 2027, with industry decline of about 2% in 2026.

Med

Sylvamo Corporation Q3 2026 Earnings Call Summary

Sylvamo Corporation reported Q3 2026 earnings, highlighting a strategic pivot to North and Latin America, operational improvements, and planned divestiture of European business by Q1 2027. The company expects $6M higher input costs in Q4 2026 and projects flat North American volume in 2027. Management deferred new free cash flow targets until the European sale is finalized, prioritizing balance sheet strength and high-return projects.

$SLVMMed

Sylvamo Reports Third Quarter 2026 Earnings

Sylvamo (SLVM) reported Q3 2026 earnings, with net sales of $645M from continuing operations and net income of $85M ($2.13 per share). The company announced a potential sale of its Europe business to Midas Atlantic Partners and The Najafi Companies. Sylvamo declared a $0.45 per share dividend and is investing in strategic projects at its Eastover mill. The company expects to focus on Latin America and North America post-transaction.

$SLVMMed

Sylvamo 3Q 2026: Revenue $645M, EPS ($4.98) — 10-Q Summary

Sylvamo reported 3Q 2026 revenue of $645M, down 2.6% YoY, and a net loss of $199M, a 449.1% decline. Lower volume from the Riverdale mill agreement termination impacted sales, while higher costs pressured profits. A Europe-segment impairment drove the net loss. Capital spending was $156M for the first nine months of 2026.